| 1 | Representative(s) Homan offered the following: |
| 2 |
|
| 3 | Amendment (with directory and title amendments) |
| 4 | Remove lines 176-701 and insert: |
| 5 | to methodologies set forth in the rules of the agency and in |
| 6 | policy manuals and handbooks incorporated by reference therein. |
| 7 | These methodologies may include fee schedules, reimbursement |
| 8 | methods based on cost reporting, negotiated fees, competitive |
| 9 | bidding pursuant to s. 287.057, and other mechanisms the agency |
| 10 | considers efficient and effective for purchasing services or |
| 11 | goods on behalf of recipients. If a provider is reimbursed based |
| 12 | on cost reporting and submits a cost report late and that cost |
| 13 | report would have been used to set a lower reimbursement rate |
| 14 | for a rate semester, then the provider's rate for that semester |
| 15 | shall be retroactively calculated using the new cost report, and |
| 16 | full payment at the recalculated rate shall be effected |
| 17 | retroactively. Medicare-granted extensions for filing cost |
| 18 | reports, if applicable, shall also apply to Medicaid cost |
| 19 | reports. Payment for Medicaid compensable services made on |
| 20 | behalf of Medicaid eligible persons is subject to the |
| 21 | availability of moneys and any limitations or directions |
| 22 | provided for in the General Appropriations Act or chapter 216. |
| 23 | Further, nothing in this section shall be construed to prevent |
| 24 | or limit the agency from adjusting fees, reimbursement rates, |
| 25 | lengths of stay, number of visits, or number of services, or |
| 26 | making any other adjustments necessary to comply with the |
| 27 | availability of moneys and any limitations or directions |
| 28 | provided for in the General Appropriations Act, provided the |
| 29 | adjustment is consistent with legislative intent. |
| 30 | (2) |
| 31 | (b) Subject to any limitations or directions provided for |
| 32 | in the General Appropriations Act, the agency shall establish |
| 33 | and implement a Florida Title XIX Long-Term Care Reimbursement |
| 34 | Plan (Medicaid) for nursing home care in order to provide care |
| 35 | and services in conformance with the applicable state and |
| 36 | federal laws, rules, regulations, and quality and safety |
| 37 | standards and to ensure that individuals eligible for medical |
| 38 | assistance have reasonable geographic access to such care. |
| 39 | 1. Changes of ownership or of licensed operator do not |
| 40 | qualify for increases in reimbursement rates associated with the |
| 41 | change of ownership or of licensed operator. The agency shall |
| 42 | amend the Title XIX Long Term Care Reimbursement Plan to provide |
| 43 | that the initial nursing home reimbursement rates, for the |
| 44 | operating, patient care, and MAR components, associated with |
| 45 | related and unrelated party changes of ownership or licensed |
| 46 | operator filed on or after September 1, 2001, are equivalent to |
| 47 | the previous owner's reimbursement rate. |
| 48 | 2. The agency shall amend the long-term care reimbursement |
| 49 | plan and cost reporting system to create direct care and |
| 50 | indirect care subcomponents of the patient care component of the |
| 51 | per diem rate. These two subcomponents together shall equal the |
| 52 | patient care component of the per diem rate. Separate cost-based |
| 53 | ceilings shall be calculated for each patient care subcomponent. |
| 54 | The direct care and indirect care subcomponents subcomponent of |
| 55 | the per diem rate shall be limited by the cost-based class |
| 56 | ceiling, and the indirect care subcomponent shall be limited by |
| 57 | the lower of a the cost-based class ceiling, a by the target |
| 58 | rate class ceiling, or an by the individual provider target for |
| 59 | each subcomponent. The agency shall adjust the patient care |
| 60 | component effective January 1, 2002. The cost to adjust the |
| 61 | direct care subcomponent shall be the net of the total funds |
| 62 | previously allocated for the case mix add-on. The agency shall |
| 63 | make the required changes to the nursing home cost reporting |
| 64 | forms to implement this requirement effective January 1, 2002. |
| 65 | 3. The direct care subcomponent shall include salaries and |
| 66 | benefits of direct care staff providing nursing services |
| 67 | including registered nurses, licensed practical nurses, and |
| 68 | certified nursing assistants who deliver care directly to |
| 69 | residents in the nursing home facility. This excludes nursing |
| 70 | administration, MDS, and care plan coordinators, staff |
| 71 | development, and staffing coordinator. |
| 72 | 4. All other patient care costs shall be included in the |
| 73 | indirect care cost subcomponent of the patient care per diem |
| 74 | rate. There shall be no costs directly or indirectly allocated |
| 75 | to the direct care subcomponent from a home office or management |
| 76 | company. |
| 77 | 5. On July 1 of each year, the agency shall report to the |
| 78 | Legislature direct and indirect care costs, including average |
| 79 | direct and indirect care costs per resident per facility and |
| 80 | direct care and indirect care salaries and benefits per category |
| 81 | of staff member per facility. |
| 82 | 6. In order to offset the cost of general and professional |
| 83 | liability insurance, the agency shall amend the plan to allow |
| 84 | for interim rate adjustments to reflect increases in the cost of |
| 85 | general or professional liability insurance for nursing homes. |
| 86 | This provision shall be implemented to the extent existing |
| 87 | appropriations are available. |
| 88 |
|
| 89 | It is the intent of the Legislature that the reimbursement plan |
| 90 | achieve the goal of providing access to health care for nursing |
| 91 | home residents who require large amounts of care while |
| 92 | encouraging diversion services as an alternative to nursing home |
| 93 | care for residents who can be served within the community. The |
| 94 | agency shall base the establishment of any maximum rate of |
| 95 | payment, whether overall or component, on the available moneys |
| 96 | as provided for in the General Appropriations Act. The agency |
| 97 | may base the maximum rate of payment on the results of |
| 98 | scientifically valid analysis and conclusions derived from |
| 99 | objective statistical data pertinent to the particular maximum |
| 100 | rate of payment. |
| 101 | (14) A provider of prescribed drugs shall be reimbursed |
| 102 | the least of the amount billed by the provider, the provider's |
| 103 | usual and customary charge, or the Medicaid maximum allowable |
| 104 | fee established by the agency, plus a dispensing fee. |
| 105 | (a) For pharmacies with less than $75,000 in average |
| 106 | aggregate monthly payments, the Medicaid maximum allowable fee |
| 107 | for ingredient cost will be based on the lower of: average |
| 108 | wholesale price (AWP) minus 15.4 percent, wholesaler acquisition |
| 109 | cost (WAC) plus 5.75 percent, the federal upper limit (FUL), the |
| 110 | state maximum allowable cost (SMAC), or the usual and customary |
| 111 | (UAC) charge billed by the provider. |
| 112 | (b) For pharmacies with $75,000 or more in average |
| 113 | aggregate monthly payments, the Medicaid maximum allowable fee |
| 114 | for ingredient cost will be based on the lower of: average |
| 115 | wholesale price (AWP) minus 17 percent, wholesaler acquisition |
| 116 | cost (WAC) plus 3.5 percent, the federal upper limit (FUL), the |
| 117 | state maximum allowable cost (SMAC), or the usual and customary |
| 118 | (UAC) charge billed by the provider. |
| 119 | (c) Medicaid providers are required to dispense generic |
| 120 | drugs if available at lower cost and the agency has not |
| 121 | determined that the branded product is more cost-effective, |
| 122 | unless the prescriber has requested and received approval to |
| 123 | require the branded product. The agency is directed to implement |
| 124 | a variable dispensing fee for payments for prescribed medicines |
| 125 | while ensuring continued access for Medicaid recipients. The |
| 126 | variable dispensing fee may be based upon, but not limited to, |
| 127 | either or both the volume of prescriptions dispensed by a |
| 128 | specific pharmacy provider, the volume of prescriptions |
| 129 | dispensed to an individual recipient, and dispensing of |
| 130 | preferred-drug-list products. The agency may increase the |
| 131 | pharmacy dispensing fee authorized by statute and in the annual |
| 132 | General Appropriations Act by $0.50 for the dispensing of a |
| 133 | Medicaid preferred-drug-list product and reduce the pharmacy |
| 134 | dispensing fee by $0.50 for the dispensing of a Medicaid product |
| 135 | that is not included on the preferred drug list. The agency may |
| 136 | establish a supplemental pharmaceutical dispensing fee to be |
| 137 | paid to providers returning unused unit-dose packaged |
| 138 | medications to stock and crediting the Medicaid program for the |
| 139 | ingredient cost of those medications if the ingredient costs to |
| 140 | be credited exceed the value of the supplemental dispensing fee. |
| 141 | The agency is authorized to limit reimbursement for prescribed |
| 142 | medicine in order to comply with any limitations or directions |
| 143 | provided for in the General Appropriations Act, which may |
| 144 | include implementing a prospective or concurrent utilization |
| 145 | review program. |
| 146 |
|
| 147 | =========== D I R E C T O R Y A M E N D M E N T ========== |
| 148 | Remove line 171 and insert: |
| 149 | Section 6. Paragraph (b) of subsection (2) and subsection |
| 150 | (14) of section 409.908, Florida Statutes, are amended |
| 151 |
|
| 152 | ================ T I T L E A M E N D M E N T ============= |
| 153 | Remove lines 14 and 15 and insert: |
| 154 | F.S.; revising provisions |